2024 Mentorship Award: Susan Kaech is a Salk Institute Professor, Director of the NOMIS Center for Immunobiology and Microbial Pathogenesis, and holder of the NOMIS Chair
Awards

Susan Kaech is the 2024 ICIS Mentorship Award Winner

Susan Kaech is the 2024 ICIS Mentorship Award Winner in recognition not only of her cutting-edge research and seminal discoveries and scientific accomplishment, but for her ardent sponsorship and relentless championship of the junior faculty she has helped in the establishment and success of their own independent research programs. She is known as a “forever-mentor” who cares more about her trainees (and often those completely unrelated to her lab) than she does about her own career, strongly supporting people in her lab long after they have left the lab. [READ MORE]

ICIS Member and 2019 Milstein Award Winner, Professor Akiko Iwasaki, renowned immunologist, has been named to both the TIME100 and TIME100 Health, two of Time Magazine's lists of the most influential people of 2024. The honor recognizes her pioneering research into post-acute infection syndromes like LlongCOVID.
Members in the News

ICIS Member Akiko Iwasaki has been named to both the TIME100 and TIME100 Health Lists of Most Influential People & in Health in 2024

ICIS Member and 2019 Milstein Award Winner, Professor Akiko Iwasaki, renowned immunologist, has been named to both the TIME100 and TIME100 Health, two of Time Magazine’s lists of the most influential people of 2024. The honor recognizes her pioneering research into post-acute infection syndromes like LongCOVID. [READ MORE]

Georg Schett Courtesy Uniklinikum Erlangen/Simone Kessler—SIMOarts
Members in the News

Georg Schett’s Autoimmunity breakthrough recognized by inclusion in the Time100 Health List of 100 Most Influential People in Health in 2024

Dr. Georg Schett, a world renown rheumatologist at the University Hospital Erlangen in Germany who chaired Cytokines 20219 in Vienna, has been named to Time Magazine’s 100 Most Influential People in Health for 2024 for his work using CAR T therapy to treat Autoimmune Diseases. Dr. Schett saw the potential of new immune-based therapy CAR T which dramatically improved outcomes for patients with certain blood cancers that involve B cells, like leukemia and lymphoma, as a promising treatment for autoimmune diseases like lupus, in which immune B cells attack the body’s own cells. He performed the first CAR T treatments on five patients with the disease in 2022. Eight months after receiving the therapy, all five were in remission and no longer needed powerful immunosuppressive drugs to control their disease. Last year, Schett published a second groundbreaking study showing that another small group of patients receiving the therapy were still in remission more than two years later without immunosuppressive drugs. [READ MORE]

Distinguished Lecturer Christopher A. Hunter’s lecture, From parasites to mRNA vaccines: cytokine networks that dictate T cell tempo
Members in the News
Cytokines Regulating Neuroimmunometabolism Session Chairs: Lydia Lynch, Princeton University and Ai Ing Lim, Princeton University
Meeting Report

Cytokines Regulating Neuroimmunometabolism Session Chairs: Lydia Lynch, Princeton University and Ai Ing Lim, Princeton University

International Cytokine & Interferon Society (ICIS) Symposium at AAI 2024 in Chicago:
Cytokines Regulating Neuroimmunometabolism
Session Chairs: Lydia Lynch, Princeton University and Ai Ing Lim, Princeton University

Description: The role of cytokines in non-classical immune-related physiology, focusing on how cytokines regulate neuroimmunology and metabolism, as well as the emerging field linking all 3 systems in ‚neuroimmunometabolism‘.

Speakers:
Lydia Lynch, Princeton University, USA, “Evolution of a cytokine neuroimmunometabolism pathway”
Ai Ing Lim, Princeton University, USA, “Cytokines regulating neuroimmunometabolism in maternal-offspring development”
Ruadhri Jackson, Harvard Medical School, USA, “An enteric neuroImmune circuit drives colorectal cancer”
Rami Bechara, University of Paris-Saclay, INSERM, France, “IL-17 as a regulator of metabolism in target cells”
Vishva Deep Dixit , Yale University, USA, “Adipose macrophages and regulation of neuroimmunometabolism”
[READ MORE]

We've Moved
Society News

We’ve Moved!

The ICIS continues to be managed as a virtual office, now with one office in San Francisco and one in Germany. Since the society is a US registered non-profit organization that has been incorporated in the US, and Co-Managing Director, Stephanie Flores is located in San Francisco, please use the [READ MORE]

5th & 6th top things to see in Seoul
Annual Meeting

Top 10 “must visit” places in Seoul — continued…

Local Organizing Committee’s next two on the list of 10 “must visit” places in Seoul. Thanks to the Cytokines 2024 LOC member Jae Hun Shin, PhD, Yonsei University, Korea, we will feature two of the top 10 things to do in Seoul. If you missed the first four please click [READ MORE]

CONGRATULATIONS TO RUTH A FRANKLIN AND ZHENYU ZHONG
Featured Article!

ICIS Young Investigator Award Alumni Ruth Franklin & Zhenyu Zhong Receive AAI ASPIRE Awards at AAI 2024

ICIS members Dr Ruth A Franklin and Dr Zhenyu Zhong received the AAI ASPIRE Award at this year’s Annual Meeting of the American Association of Immunologist (AAI2024), held in Chicago from May 3rd to 7th, where they also had the opportunity to present their research via podium presentations. The AAI [READ MORE]

Yanick J. Crow has been chosen for the 2024 ICIS-Pfizer Award for Excellence in Cytokine & Interferon Research
Awards

Yanick J. Crow has been chosen for the 2024 ICIS-Pfizer Award for Excellence in Cytokine & Interferon Research

Yanick J. Crow has been selected as the 2024 ICIS-Pfizer Award for Excellence in Interferon and Cytokine Research in recognition for his groundbreaking research on Type I Interferonopathies which has revolutionized the fields of basic and clinical immunology with phenomenal clinical and biological implications. Professor Crow is recognized as one of the top three scientists in the field of human inborn errors of immunity and the founder of the rapidly growing and revolutionary field of “Type I interferonopathies,” making him a most deserving recipient for the ICIS-Pfizer Award for Excellence in Cytokine & Interferon Research. [READ MORE]

Stefan Rose-John is recognized as the 2024 ICIS-BioLegend William E. Paul Award
Awards

Stefan Rose-John is recognized as the 2024 ICIS-BioLegend William E. Paul Award

Stefan Rose-John is recognized as the 2024 ICIS-BioLegend William E. Paul Award winner in recognition for his seminal contributions to the field of cytokine biology. With a primary focus on the IL-6 cytokine family, his fundamental research has pioneered several paradigm-shifting discoveries, which have steered understanding of IL-6 in physiology and pathophysiology. Moreover, these insights have informed refinements affecting how target IL-6 for therapy. By presenting this Award, which is generously sponsored by BioLegend, the ICIS recognizes Professor Rose-John as one of a rare breed of scientists who has excelled in discovery science, achieved success as an entrepreneur, and translated his basic scientific discoveries into treatments that directly ameliorate patients’ lives. [READ MORE]